Skip to main content
Premium Trial:

Request an Annual Quote

UK Research Councils to Fund Second Round of Systems Biology Centers

NEW YORK, April 6 (GenomeWeb News) - the UK's Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council have opened a second call for proposals to fund several Centers for Integrative Systems Biology.


The opportunity is open to all UK universities, but universities that received funding in the first round of the initiative, which began last June, are not expected to apply again.


Proposals may request up to £5 million ($9.4 million) from BBSRC, and an additional £1 million "is available to each center to facilitate the building of multidisciplinary teams through the engagement of physical scientists and mathematicians." EPSRC will also contribute some funding for the initiative, but the amount was not disclosed. Applicants are "advised to contact" the EPSRC before submitting their outline to BBSRC.


The councils did not provide details about how many centers they expect to fund under the initiative.


The councils said they will consider requests for start-up funding, for up to five years, towards the costs of advanced research equipment, research and support staff, and support for an initial research program.


Expressions of interest should be submitted by June 13.  From these, "a small number" will be selected to prepare full bids that will be due December 1.


Further details are available here.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more